Earlier settlement between rivals Abbott and Dexcom does not bar Abbott from challenging patents at the Patent Trial and Appeal Board | 6mos
Earlier settlement between rivals Abbott and Dexcom does not bar Abbott from challenging patents at the Patent Trial and Appeal Board | 6mos
Team advising medtech company on dispute before USPTO helped found A&O’s West Coast practice | 7mos
IP firm believe the newly established court is interpreting the public access rules too restrictively, looks to the EPO as a ‘paragon of openness’ in this area | 7mos
Service aims to settle IP disputes in a single process avoiding the expense and complexity of litigation | 8mos
The Commercial Litigation and Cross-border Enforcement Law Over Borders Comparative Guide provides a highly practical and up-to-date overview of the litigation, arbitration and alternative dispute resolution landscape in some of the key international dispute resolution jurisdictions. | 10mos
Editors:
USPTO seeks to encourage “broader participation” in bar | 8mos
Data specialist Maureen Daly joins from Beauchamps as Pinsents moves to build Europe tech and science sector offering | 8mos
IP filings have “braved” the pandemic, but WIPO director general warns of geopolitical instability and an uncertain economic outlook | 8mos
Quartet of patent experts joins recent Cooley hire Amy Baker Mandragouras to boost Foley’s life sciences IP practice | 9mos
Join brand protection managers, law enforcement and technology innovators on 18 October to share best practice in the fight against counterfeits | 9mos
Rouse beefs up its intellectual property enforcement team with two new appointments in response to client need amid the changing anti-counterfeiting landscape | 9mos
Eve Alexander, head of intelligence analysis at the UK’s Intellectual Property Office, examines the sweeping changes in the counterfeiting landscape over the last decade | 10mos
Hemmie Chang joins to lead new life sciences-focused office | 10mos
Veteran litigators join amid uptick in federal and state regulatory scrutiny facing product manufacturers | 10mos
Move marks latest round in Covid-19 mRNA vaccine patent litigation battle | 10mos
Nine weeks in and figures reveal the UP is proving popular with roughly 700 requests a week | 11mos
Cincinnati-based firm adds 19 lawyers and nearly two dozen business professionals through merger with Mateer & Harbert | 11mos
Five patents relating to groundbreaking gene editing technology cannot be quashed by interference proceedings used in previous US patent system | 1yr
Sapna Dutta to succeed Elizabeth Messud as FTSE 100 company’s top lawyer in October | 1yr
Andrei Iancu and Kathleen O’Malley join from Irell & Manella to bolster US firm’s patent practice in Los Angeles and Washington DC | 1yr
Veteran government litigator Coke Morgan Stewart joins firm’s Washington DC office | 1yr